Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ocugen Inc
(NQ:
OCGN
)
1.555
-0.045 (-2.81%)
Streaming Delayed Price
Updated: 1:06 PM EDT, Jun 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen Inc
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
31
32
Next >
Why Ocugen Stock Skyrocketed 339% in the First Half of 2021
July 14, 2021
The big jump resulted from the company's partnership with Bharat Biotech to commercialize COVID-19 vaccine Covaxin.
Via
The Motley Fool
Exposures
COVID-19
Ocugen’s Recent Vaccine Efficacy Results Should Have Traders Cheering
July 12, 2021
While the Delta variant Covid-19 strain threatens the population, OCGN stock investors can count on Ocugen to advance its vaccine candidate.
Via
InvestorPlace
Exposures
COVID-19
Why Shares of Ocugen Are Dropping Today
July 09, 2021
Investors may be getting concerned about how long it may take for COVID-19 vaccine Covaxin to get approved.
Via
The Motley Fool
Exposures
COVID-19
The Outlook for Ocugen Stock Has Deteriorated Further
July 07, 2021
Phase 3 data on Covaxin wasn't outstanding, and there are indications that demand for additional vaccines in the U.S. and Canada will be low for some time. OCGN remains a good stock to short.
Via
InvestorPlace
Exposures
COVID-19
What's Next For Ocugen Stock As It Nears Key Resistance Level?
July 06, 2021
Ocugen Inc. (NASDAQ: OCGN) shares traded higher Tuesday after the company announced that its coronavirus vaccine co-development partner Bharat Biotech reported...
Via
Benzinga
Exposures
COVID-19
42 Stocks Moving In Tuesday's Mid-Day Session
July 06, 2021
Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 74% to $9.47. BSQUARE Corporation (NASDAQ: BSQR) shares jumped 48.2% to $5.90 after dropping around 10% on Friday. Bridgeline...
Via
Benzinga
3 Reasons Ocugen Stock Should Maintain Its Upward Trajectory
July 06, 2021
OCGN stock has been counted out of the vaccine race many times, but there is plenty of room for optimism moving forward.
Via
InvestorPlace
OCGN Stock: The Big Covaxin News That Has Ocugen Rallying Today
July 06, 2021
OCGN stock is racing higher this morning following better-than-expected results from Ocugen's vaccine partner. Here is what you need to know.
Via
InvestorPlace
Exposures
COVID-19
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 06, 2021
Gainers Advaxis (NASDAQ:ADXS) stock rose 46.9% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $100.9 million. Axcella...
Via
Benzinga
Ocugen Preps US Filings For COVID-19 Vaccine As New Data Shows Overall Efficacy Of Around 79%
July 06, 2021
Armed with new data from its development partner Bharat Biotech, Ocugen Inc (NASDAQ: OCGN) plans to press ahead with plans to file for approval of their COVID-19...
Via
Benzinga
Exposures
COVID-19
28 Stocks Moving in Tuesday's Pre-Market Session
July 06, 2021
Gainers Odonate Therapeutics, Inc. (NASDAQ: ODT) shares rose 38.3% to $4.80 in pre-market trading following 13G from Ikarian Capital showing a 5.2% stake in the company. BSQUARE...
Via
Benzinga
Don’t Play the Ocugen Stock Short Squeeze Before You Read This Warning!
July 06, 2021
Growing trends involving OCGN stock suggest that the bears may have the upper hand this time.
Via
InvestorPlace
Exposures
COVID-19
Ocugen Has Had a Good Run, but the Math Says It’s Over
July 06, 2021
Ocugen was a penny stock is up 180% for the year. But all good things must come to an end. And it’s time to let go of OCGN stock.
Via
InvestorPlace
Exposures
COVID-19
3 Tips for Coronavirus Investing Right Now
July 05, 2021
Whether you're a cautious or aggressive investor, there's something for you in this space.
Via
The Motley Fool
Topics
Cannabis
Exposures
COVID-19
Cannabis
One Bright Spot for Ocugen Investors
July 03, 2021
It may equal some coronavirus vaccine revenue ahead.
Via
The Motley Fool
Topics
Cannabis
Exposures
COVID-19
Cannabis
12 Health Care Stocks Moving In Friday's After-Market Session
July 02, 2021
Gainers Odonate Therapeutics (NASDAQ:ODT)...
Via
Benzinga
Opportunity for Investors With Substantial Losses to Lead the Ocugen, Inc. Class Action Lawsuit - OCGN
July 02, 2021
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
How Risky Is Ocugen After Its Recent Setback?
July 02, 2021
The U.S. vaccine market has slipped farther out of reach.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Better Short-Squeeze Stock: Clover Health or Ocugen?
July 02, 2021
Both have the necessary ingredients for explosive short-squeeze returns.
Via
The Motley Fool
Why Ocugen Shares Are Slipping Today
July 01, 2021
It could be due to the aftereffects of being included in a major stock index.
Via
The Motley Fool
Sell Ocugen Stock Before the Other Shoe Finally Drops
June 30, 2021
The bad news with Covaxin hasn't sunk in yet with OCGN stock investors, so get out while the stock still remains elevated.
Via
InvestorPlace
Exposures
COVID-19
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
June 30, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
What's Going On With Ocugen (OCGN) Stock Today?
June 30, 2021
Ocugen Inc (NASDAQ: OCGN) shares are trading 1.6% higher in the pre-market session on Wednesday amid high social media interest. The company's shares had closed nearly 2%...
Via
Benzinga
ROSEN, A LEADING LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important August 17 Deadline in Securities Class Action – OCGN
June 29, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
NASDAQ:OCGN Shareholder Alert: Lawsuit Alleges Securities Laws Violations by Ocugen, Inc.
June 29, 2021
San Diego, CA -- (SBWIRE) -- 06/29/2021 -- An investor, who purchased NASDAQ:OCGN shares, filed a lawsuit against Ocugen, Inc. over alleged violations of Federal Securities Laws.
Via
SBWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
If Ocugen Stock Is Worth $8, I’ll Eat My Hat
June 29, 2021
OCGN stock at $8.35 looks ridiculously overvalued given the change in course
Via
InvestorPlace
Exposures
COVID-19
OCGN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ocugen, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
June 29, 2021
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Ocugen Stock Is A Bust After Covaxin’s Emergency Use Rejection
June 29, 2021
OCGN stock is of no value to investors now that federal regulators closed the door on its Covid-19 vaccine commercialization efforts.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
Is It Too Late to Buy Ocugen Stock?
June 29, 2021
The company has found a partner to manufacture its COVID-19 vaccine -- but will it be all for naught?
Via
The Motley Fool
Exposures
COVID-19
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
June 29, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.